Literature DB >> 31499214

Recovery and Post-Thaw Assessment of Human Umbilical Cord Blood Cryopreserved as Quality Control Segments and Bulk Samples.

Peter Kilbride1, Julie Meneghel2, Stephen Lamb2, John Morris2, Jerome Pouzet3, Monika Jurgielewicz4, Christopher Leonforte4, Daniel Gibson4, Alejandro Madrigal4.   

Abstract

Quality control (QC) segments conjoined to a bulk sample container are used to evaluate the viability and quality of cryopreserved umbilical cord blood (UCB). Such QC segments are typically attached lengths of sealed tubing that are cooled concurrently with the bulk sample, both containing material from the same donor. QC segments are thawed independently of the bulk sample to assess the quality of the cryopreserved product. In current practice, there is typically post-thaw variation between the QC segment and the bulk sample which if suggestive of inadequate performance, could lead to material being needlessly discarded. In this study, these performance differences were quantified. Two cooling protocols in common use, 1 with and 1 without a "plunge" step to induce ice nucleation, gave equivalent results that maintained the QC segment versus bulk sample differences. Ice nucleated at significantly lower temperatures in the QC segments compared with the bulk samples, a consequence of their lower volume, thereby enhancing damaging osmotic stress. A reduction in total viable cells of approximately 10% was recorded in the QC segments compared with comparable bulk samples. It has been shown that CD45+ cells are more adversely impacted by this lower ice nucleation temperature than CD34+ cells, which can result in altered composition of the post-thaw cell population.
Copyright © 2019 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cord blood; Cryopreservation; Linear cooling; Plunge cooling; Quality control

Mesh:

Year:  2019        PMID: 31499214     DOI: 10.1016/j.bbmt.2019.09.004

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  4 in total

Review 1.  Chemical approaches to cryopreservation.

Authors:  Kathryn A Murray; Matthew I Gibson
Journal:  Nat Rev Chem       Date:  2022-07-18       Impact factor: 34.571

Review 2.  Cryopreservation as a Key Element in the Successful Delivery of Cell-Based Therapies-A Review.

Authors:  Julie Meneghel; Peter Kilbride; G John Morris
Journal:  Front Med (Lausanne)       Date:  2020-11-26

3.  Cryopreservation of primary cultures of mammalian somatic cells in 96-well plates benefits from control of ice nucleation.

Authors:  Martin I Daily; Thomas F Whale; Riitta Partanen; Alexander D Harrison; Peter Kilbride; Stephen Lamb; G John Morris; Helen M Picton; Benjamin J Murray
Journal:  Cryobiology       Date:  2020-02-21       Impact factor: 2.487

4.  Automated dry thawing of cryopreserved haematopoietic cells is not adversely influenced by cryostorage time, patient age or gender.

Authors:  Peter Kilbride; Julie Meneghel; Giovanna Creasey; Fatemeh Masoudzadeh; Tina Drew; Hannah Creasey; David Bloxham; G John Morris; Kevin Jestice
Journal:  PLoS One       Date:  2020-10-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.